Clinical Research in India

A pharma company designs a Phase-2 or Phase-3 trial. You are the operational owner: you qualify investigator sites, train hospital staff on the protocol, monitor source documents against the CRF (SDV), audit informed consent, raise deviation reports, and own the site relationship until database lock. As you grow, you stop visiting sites and start running the whole study (CTM / Project Manager). The trial cannot run without you.

India is now the second-largest patient pool for global trials after the US, and the new clinical-trial rules (NDCT 2019 + DCGI fast-track) have re-opened MNC sponsor activity. Every CRO is expanding India operations. ~12,000 active CRA/CRC openings on Naukri at any given time.

Global clinical trials services market: ~$60B in 2025; India captures ~$3.5B of execution work and is growing 14% YoY (IQVIA Institute 2025).

Who fits: B.Pharm, M.Pharm, Pharm.D, B.Sc Nursing, MBBS, BDS, BAMS, BHMS, BPT, M.Sc Life Sciences. Travel-readiness is the decisive non-degree filter for CRA roles. CRC roles are site-based (no travel).

1. Step 1Y0

   Clinical Research Coordinator (site)

   ₹3.5 – 6 LPA

   Unlock: GCP cert + 1 year of site-level CRF + EC submission reps

2. Step 2Y2

   CRA L1 (in-house) → Field CRA

   ₹6.5 – 11 LPA

   Unlock: First independent monitoring visit + ACRP CCRA prep

3. Step 3Y5

   Senior / Lead CRA

   ₹12 – 18 LPA

   Unlock: ACRP CCRA + multi-site oversight + co-monitor reviews

4. Step 4Y8+

   Clinical Trial Manager / Project Manager

   ₹20 – 32 LPA

   Unlock: Owns end-to-end study budget, timelines and sponsor relationship

• Clinical Research Coordinator (CRC) — site-based
• Clinical Research Associate (CRA L1)
• Senior CRA / Lead CRA
• Clinical Trial Manager (CTM)
• Site Activation Specialist
• Clinical Project Manager

• ACRP CCRA / CCRC

  +₹1.5–2L at offer; near-mandatory for MNC CRO promotion to Sr CRA

• SoCRA CCRP

  +₹1L; favoured by US-aligned sponsors

• GCP refresher (TransCelerate-recognised)

  Annual requirement; gates billable monitoring days

• CRC vs CRA — which to start with?

  CRC if you want hospital-based, no-travel work and have a nursing/pharmacy background tied to a city. CRA if you can travel 12-15 days/month and want the higher pay band by Y3. CRA pay overtakes CRC by ₹2-3 LPA from Y2 onwards.

• Is CRA travel really that much?

  Field CRA: 10-15 monitoring days/month at sponsor sites across India. In-house CRA (RBM): 0 travel, slightly lower pay. Most MNC CROs now offer the in-house option, which is what makes the role accessible to women returners and parents.

• Do I need ACRP/SoCRA certification?

  Not for L1, yes by Y3 in MNC CROs. ACRP CCRA is the global standard and adds ₹1.5-2L at promotion; without it, the Senior CRA step often gets blocked.

• Can a fresher get CRA without going through CRC first?

  Rare in India. The standard path is CRC (1-2 yr) → in-house CRA (1 yr) → field CRA. A few MNCs (IQVIA, Parexel) hire M.Pharm freshers directly into in-house CRA at ₹5-7 LPA via structured graduate programmes.

• Are clinical trials in India safe long-term, given regulatory history?

  Yes, post-2019. NDCT 2019 + Schedule Y reforms restored MNC sponsor confidence; trial registrations on CTRI are at all-time highs. The 2013-2018 slowdown is behind the industry.

• Best abroad route for CRAs?

  UK and Ireland — both run structural CRA shortages and accept Indian ACRP-certified CRAs at Y4+. UAE is the fastest visa but the market is smaller. USA H1B for CRAs is rare; the role tends to stay onshore.